Ulimorelin, if approved, is expected to be a first-in-class drug for the treatment of gastrointestinal (GI) dysmotility indications in acute care settings. Ulimorelin is a small molecule, intravenously-administered
With the completion of the design of the self-metering cartridge, a limited production run will be released, which will enable the company to adapt its first cardiovascular test,
Through the deal, American Medical Systems has a four year option to obtain distribution and license rights to Tissue Genesis’ regenerative cell technology including the Tissue Genesis Cell
First Response has patent pending technology that can detect the pregnancy hormone, human chorionic gonadotropin (hCG), up to six days before the day of a woman’s missed period,
The research, carried out over three months at Europe’s largest imaging centre, illustrates the changes taking place inside someone’s body as they take alli plus diet. It supports
Galectin-3 has been shown by researchers at the University of Maastricht, the Netherlands, to play an integral role in the development and progression of heart failure. The company
Enzon’s specialty pharmaceutical business includes four marketed products, Oncaspar, Adagen, DepoCyt, and Abelcet, as well as a manufacturing facility in Indianapolis, Indiana. As previously announced, Enzon entered into
Eddie Catalfamo, president and CEO of Santica Research Labs, said: “This unique supplement, made from carefully selected natural botanical extracts, targets the underlying factors that contribute to the
Fourth quarter 2009 sales posted by the company were $1.64 billion, compared to fourth quarter 2008 sales of $1.60 billion. Sales increased 2% as favorable foreign currency exchange
The company said that its specialty amines such as DMAPAPA, TMPDA, DEAPA and APDEA offer the advantage of a multipurpose behavior in two-component systems, as they play a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.